Other Headlines
Have News for Us?
Submit your news on the industry, people, or companies.
Forward to a FriendMore News Headlines
Sg2 Announces Its INSIGHT System to Improve Hospitals' Clinical Performance and Bottom Line Results Future-focused performance management system prepares hospital leaders for the changing health care environment.
Fiber Laser Pioneer, Dr. Valentin P. Gapontsev Awarded 2009 Arthur L. Schawlow Award Honor bestowed at the 28th International Congress on Applications of Lasers and Electro-Optics (ICALEO®).
HIMSS Electronic Health Record Association Supports Standards in HIT Standards Committee Testimony Workgroup advises the Office of the National Coordinator for Health IT (ONC).
Philips Ranks First in Overall Service in 2009 IMV Ultrasound Report Results mark 17th consecutive year for top performance in IMV ServiceTrak™ ultrasound.
Calypso Medical Studies Show Potential for Improving Radiotherapy Treatment Accuracy More than 30 Calypso-related scientific studies presented at ASTRO.
Digisonics DigiView Offers CIMT Screening, Among Other Vascular Study Types CIMT Screening is one of many study types available with Digisonics DigiView.
Broadwest and Three Palm Software Partner Broadwest and Three Palm Software have signed a partnership agreement in which Broadwest will distribute Three Palm Software's WorkstationOne™ product.
Nolato Medical Expands its Swedish Technology Centre World-leading supplier to the medical device industry expands its Technology Centre in southern Sweden to meet increased demand from its customers for more complex product development.
New CARESTREAM DRX-Evolution Delivers Unmatched Positioning Ease Carestream Health provides a preview of an RSNA hot ticket item.
Toumaz Technology and Imperial College London in Landmark Clinical Trial Of Sensium™-Enabled Digital Plaster "Digital Plaster" wireless vital signs monitor now being trialed in patient settings in milestone Imperial College London study.
annually captures the
4,000 largest U.S. stocks
EnteroMedics Makes Russell 3000(R) Index
The Russell's U.S. index annually captures the 4,000 largest U.S. stocks, ranking them by total market capitalization.
EnteroMedics' membership in the Russell 3000 will remain effective for a year and means that it has automatic inclusion in the small-cap Russell 2000 Index and relevant growth and value indexes. An industry-leading $4 trillion in assets are currently benchmarked to the Russell indexes.
About EnteroMedics Inc.
EnteroMedics is a development stage medical device company focused on the design and development of devices that use neuroblocking technology to treat obesity and other gastrointestinal disorders.
EnteroMedics' proprietary neuroblocking technology, VBLOC(R) vagal blocking therapy, is designed to intermittently block the vagus nerves using high-frequency, low-energy, electrical impulses. EnteroMedics has met its enrollment goal under an FDA-approved Investigational Device Exemption (IDE) for the EMPOWER(TM) Study using the Maestro(R) System, its initial product for the treatment of obesity. EnteroMedics is currently recruiting patients outside of the United States for a feasibility study examining VBLOC Therapy's effects on blood glucose levels in diabetic patients. For more information, visit www.enteromedics.com
Interested in Medical Industry News?
Subscribe to DOTmed's weekly news email and always be informed.
Click here, it takes just 30 seconds.
|
Please Send us your Comments. |
|
|
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2009 DOTmed.com, Inc.
ALL RIGHTS RESERVED
